|
ASH2L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.00090000000275E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.795200E-04 |
| Normal-vs-Stage2 |
8.024200E-04 |
| Normal-vs-Stage3 |
5.042100E-04 |
| Normal-vs-Stage4 |
8.032400E-04 |
| Stage1-vs-Stage2 |
3.381600E-01 |
| Stage1-vs-Stage3 |
4.243000E-01 |
| Stage1-vs-Stage4 |
4.688800E-01 |
| Stage2-vs-Stage3 |
7.101800E-01 |
| Stage2-vs-Stage4 |
8.170000E-01 |
| Stage3-vs-Stage4 |
9.038800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.15079999999324E-05 |
| Normal-vs-AfricanAmerican |
3.849400E-01 |
| Normal-vs-Asian |
3.783900E-02 |
| Caucasian-vs-AfricanAmerican |
1.139750E-01 |
| Caucasian-vs-Asian |
3.623400E-01 |
| AfricanAmerican-vs-Asian |
4.238000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92696999999908E-05 |
| Normal-vs-Female |
3.632900E-04 |
| Male-vs-Female |
9.164200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.262000E-03 |
| Normal-vs-Age(41-60Yrs) |
8.11660000000769E-05 |
| Normal-vs-Age(61-80Yrs) |
1.599420E-04 |
| Normal-vs-Age(81-100Yrs) |
7.682800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.492400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.546770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.438600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.215600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.233200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.328000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.120600E-01 |
| Classical-VS-Follicular |
2.006800E-04 |
| Classical-VS-Other |
8.842200E-02 |
| Classical-VS-Normal |
1.755800E-02 |
| Tall-VS-Follicular |
2.760500E-03 |
| Tall-VS-Other |
2.266800E-01 |
| Tall-VS-Normal |
6.691800E-02 |
| Follicular-VS-Other |
8.537400E-01 |
| Follicular-VS-Normal |
5.7059000002635E-07 |
| Other-VS-Normal |
7.786100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85471999999409E-05 |
| Normal-vs-N1 |
6.44979999999684E-05 |
| N0-vs-N1 |
2.515200E-01 |
|
|
